Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate Cancer

Sexual survivorship after primary treatment for prostate cancer is an important quality-of-life (QOL) metric for measuring satisfactory outcomes. Among patients surveyed, post-treatment sexual function rates highly among factors when considering treatment decisions [1]. Several high-impact studies have looked at QOL survivorship among men who are impotent or on androgen deprivation therapy (ADT) before treatment [2 –8]; few studies, such as the Prostate Cancer Outcomes and Satisfaction With Treatment Quality Assessment (PROSTQA) Consortium, provide a model for predicting post-treatment patient-reported QOL [6,7,9].

Source: Radiotherapy and Oncology - February 26, 2019 Category: Radiology Authors: Adam L. Holtzman, Curtis M. Bryant, Nancy P. Mendenhall, William M. Mendenhall, R. Charles Nichols, Randal H. Henderson, Nicholas Figura, Christopher G. Morris, Christopher R. Williams, Zoufeng Li, Bradford S. Hoppe Tags: Original Article Source Type: research